170 related articles for article (PubMed ID: 15331951)
1. [Evaluation of severity in partial intractable epilepsy].
Remy C; Biraben A; Lavernhe G
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S65-70. PubMed ID: 15331951
[TBL] [Abstract][Full Text] [Related]
2. [Criteria of severity of intractable focal epilepsy in adults].
Gélisse P; Crespel A
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S71-9. PubMed ID: 15331952
[TBL] [Abstract][Full Text] [Related]
3. [Neuropsychological profile of intractable partial epilepsies].
Lippé S; Lassonde M
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S144-53. PubMed ID: 15331960
[TBL] [Abstract][Full Text] [Related]
4. [Quality-of-life scales for patients with drug-resistant partial epilepsy].
Villeneuve N
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S376-93. PubMed ID: 15331986
[TBL] [Abstract][Full Text] [Related]
5. [Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy--preliminary results].
Picot MC; Neveu D; Kahane P; Crespel A; Gélisse P; Hirsch E; Derambure P; Dupont S; Landré E; Chassoux F; Valton L; Vignal JP; Marchal C; Rougier A; Lamy C; Semah F; Biraben A; Arzimanoglou A; Petit J; Thomas P; Dujols P; Ryvlin P
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S354-67. PubMed ID: 15331984
[TBL] [Abstract][Full Text] [Related]
6. [Health-related quality-of-life assessment for patients with refractory partial epilepsy].
Gerbaud L; Letonturier R
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S368-75. PubMed ID: 15331985
[TBL] [Abstract][Full Text] [Related]
7. [Specific medico-social supports for drug-resistant partial epilepsies].
Gonnaud PM
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S301-7. PubMed ID: 15331978
[TBL] [Abstract][Full Text] [Related]
8. [Criteria for treatment-resistant epilepsy: the neuro-pediatrician's position].
Raffo E
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S48-52. PubMed ID: 15331948
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
10. [What is the role of neuropsychological testing in the investigation and management of pharmacologically intractable partial epilepsy?].
Valton L; Mascott CR
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S154-63. PubMed ID: 15331961
[TBL] [Abstract][Full Text] [Related]
11. Changes in seizure severity and quality of life in patients with refractory partial epilepsy.
Sancho J; Iváñez V; Molins A; López Gómez V; Masramón X; Pérez M
Epilepsy Behav; 2010 Nov; 19(3):409-13. PubMed ID: 20855235
[TBL] [Abstract][Full Text] [Related]
12. [French Federation of Neurology. Consensus conference. Case management of drug-resistant epilepsy. Jury recommendations. Long text].
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S400-14. PubMed ID: 15331988
[No Abstract] [Full Text] [Related]
13. [Refractory partial epilepsy: what are the neuropediatrician's criteria for drug resistance?].
de Saint-Martin A; Hirsch E
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S43-7. PubMed ID: 15331947
[TBL] [Abstract][Full Text] [Related]
14. Sleep disturbances reported by refractory partial-onset epilepsy patients receiving polytherapy.
Xu X; Brandenburg NA; McDermott AM; Bazil CW
Epilepsia; 2006 Jul; 47(7):1176-83. PubMed ID: 16886981
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients.
Fauser S; Huppertz HJ; Bast T; Strobl K; Pantazis G; Altenmueller DM; Feil B; Rona S; Kurth C; Rating D; Korinthenberg R; Steinhoff BJ; Volk B; Schulze-Bonhage A
Brain; 2006 Jul; 129(Pt 7):1907-16. PubMed ID: 16714316
[TBL] [Abstract][Full Text] [Related]
16. [Social outcome of 20 anterior callosotomies for drug-resistant epilepsy].
Rougier A; Claverie B; Marchal C; Pedespan JM; Loiseau P
Neurochirurgie; 1995; 41(6):413-8. PubMed ID: 8815416
[TBL] [Abstract][Full Text] [Related]
17. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
Shinnar S; Pellock JM; Conry JA
Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
[TBL] [Abstract][Full Text] [Related]
18. Antiepileptic treatment against clustered seizures in benign partial epilepsy in infancy.
Okumura A; Kato T; Hayakawa F; Maruyama K; Kubota T; Natsume J; Negoro T; Watanabe K
Brain Dev; 2006 Oct; 28(9):582-5. PubMed ID: 16730937
[TBL] [Abstract][Full Text] [Related]
19. [The definition of drug resistance: an epileptologist's perspective].
Genton P
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S53-9. PubMed ID: 15331949
[TBL] [Abstract][Full Text] [Related]
20. [French Federation of Neurology. Consensus conference. Case management of drug-resistant epilepsy. Jury recommendations. Short text].
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S394-9. PubMed ID: 15331987
[No Abstract] [Full Text] [Related]
[Next] [New Search]
